Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
PUT
Sea Limited
SE
$68.1B
| $7.45M | ﹤0.01% |
+79,000
| New | +$5.96M |
|
1702
Dyne Therapeutics
DYN
$4.8B
| $7.45M | ﹤0.01% |
207,309
+128,246
| +162% | +$5.1M |
|
1703
CALL
Vertex Pharmaceuticals
VRTX
$122B
| $7.44M | ﹤0.01% |
16,000
-21,600
| -57% | -$10.4M |
|
1704
TTM Technologies
TTMI
$14.7B
| $7.44M | ﹤0.01% |
407,524
+152,456
| +60% | +$2.94M |
|
1705
Paylocity
PCTY
$8.26B
| $7.41M | ﹤0.01% |
44,897
+5,609
| +14% | +$853K |
|
1706
CALL
PNC Financial Services
PNC
$101B
| $7.39M | ﹤0.01% |
40,000
+17,800
| +80% | +$3.12M |
|
1707
Performance Food Group
PFGC
$17.8B
| $7.39M | ﹤0.01% |
94,321
-30,119
| -24% | -$2.11M |
|
1708
Credo Technology Group
CRDO
$43.8B
| $7.39M | ﹤0.01% |
239,962
-111,702
| -32% | -$3.33M |
|
1709
Cavco Industries
CVCO
$4.47B
| $7.38M | ﹤0.01% |
17,234
+10,656
| +162% | +$4.2M |
|
|
APLS
1710
DELISTED
Apellis Pharmaceuticals
APLS
| $7.38M | ﹤0.01% |
255,897
+39,019
| +18% | +$1.45M |
|
|
PCH
1711
DELISTED
PotlatchDeltic
PCH
| $7.38M | ﹤0.01% |
163,784
+97,655
| +148% | +$4.14M |
|
1712
Cactus
WHD
$5.48B
| $7.37M | ﹤0.01% |
123,562
+100,223
| +429% | +$5.83M |
|
1713
Spire
SR
$4.78B
| $7.36M | ﹤0.01% |
109,372
+61,357
| +128% | +$3.98M |
|
1714
Interactive Brokers
IBKR
$39B
| $7.35M | ﹤0.01% |
211,036
+85,572
| +68% | +$2.65M |
|
1715
SiriusXM
SIRI
$10.1B
| $7.35M | ﹤0.01% |
310,684
+287,102
| +1,217% | +$8.92M |
|
1716
First Industrial Realty Trust
FR
$8.43B
| $7.34M | ﹤0.01% |
131,111
+33,702
| +35% | +$1.82M |
|
1717
Aramark
ARMK
$14.9B
| $7.34M | ﹤0.01% |
189,418
+69,223
| +58% | +$2.44M |
|
1718
Royal Gold
RGLD
$18.4B
| $7.33M | ﹤0.01% |
52,252
-5,683
| -10% | -$778K |
|
1719
Shake Shack
SHAK
$2.86B
| $7.33M | ﹤0.01% |
71,027
-28,218
| -28% | -$2.72M |
|
1720
PUT
Rentokil
RTO
$12.3B
| $7.32M | ﹤0.01% |
+293,500
| New | +$8.69M |
|
1721
PUT
Roku
ROKU
$22.2B
| $7.32M | ﹤0.01% |
+98,000
| New | +$6.28M |
|
|
TXNM
1722
TXNM Energy Inc
TXNM
$5.92B
| $7.31M | ﹤0.01% |
166,972
+33,510
| +25% | +$1.36M |
|
1723
Timken Company
TKR
$8.99B
| $7.31M | ﹤0.01% |
86,667
+59,716
| +222% | +$4.91M |
|
1724
SiteOne Landscape Supply
SITE
$4.28B
| $7.3M | ﹤0.01% |
48,398
+20,134
| +71% | +$2.76M |
|
1725
ARK Genomic Revolution ETF
ARKG
$1.63B
| $7.3M | ﹤0.01% |
285,108
+204,283
| +253% | +$5.2M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.